Optimization of microparticle-based topical treatments for treating erectile dysfunction in patients refractory to oral PDE5 inhibitors

Medicine & Life Sciences

1. Erectile Dysfunction 100%
2. Nitric Oxide 95%
3. Phosphodiesterase 5 Inhibitors 82%
4. Prostatectomy 40%
5. lead oxide 16%
6. Therapeutics 15%
7. Animal Models 14%
8. Sildenafil Citrate 12%
9. Phosphodiesterase Inhibitors 11%
10. Nerve Endings 11%
11. Cyclic GMP 11%
12. Publications 8%
13. Prostatic Neoplasms 7%
14. Aptitude 6%
15. Pathology 6%
16. Safety 5%